MedPath

Effect of Glutamine on Reducing Myocardial Damage

Phase 3
Conditions
Acute coronary syndrome.
Acute coronary thrombosis not resulting in myocardial infarction
I24.0
Registration Number
IRCT20151109024975N10
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Age over 18 years
Candidate for open heart surgery
Preoperative sinus rhythm
Normal function of liver, renal system, pulmonary system and thyroid

Exclusion Criteria

Emergency patients
Serious water and electrolyte disorders
Unwillingness to co-operate with the patient
History of chronic lung, liver, kidney and thyroid diseases and heart failure
Age over 80 years
Pregnant and lactating women
Patients who are hypersensitive to glutamine or who are banned in any way by their administration of glutamine
Total Bilirubin more than 10 mg / dL
Creatinine clearance less than 30 ml / min
Absolute Absence of Intestinal Feeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Myocardial injury after open heart surgery. Timepoint: The day before the surgery (before the intervention) and the first and second days after surgery. Method of measurement: SOFA score.
Secondary Outcome Measures
NameTimeMethod
Duration of admission to ICU. Timepoint: Duration of admission. Method of measurement: Patients follow up.;Duration of hospitalization. Timepoint: Duration of admission. Method of measurement: Patients follow up.;Mortality. Timepoint: Duration of admission. Method of measurement: Patients follow up.
© Copyright 2025. All Rights Reserved by MedPath